Founded in 2015, Windrose Consulting Group is a privately-held global strategy firm that partners with life science companies to maximize the commercial value of their products — so they can meet today’s most critical healthcare needs. We work across a broad range of products and disease areas with services that include product commercialization, pricing and market access, and value communication. We’re committed to helping companies succeed in bringing innovations to market that enhance people’s lives. To learn more about our unique approach, visit windrosecg.com.
Pricing and market access strategy (P&MA), value communication, negotiation strategy, portfolio planning, indication expansion and launch sequencing, early market-access assessment, payer research.
We work with pharmaceutical and biotech companies from top 10 to startup.
![]() Amy MorganHead of Emerging Markets, UKamy.morgan@windrosecg.comView LinkedIn profileFollow on twitter |
|
![]() Zameer MerchantSenior Engagement Manager, UKzameer.merchant@windrosecg.comView LinkedIn profileFollow on twitter |
|
![]() Mark KohlerSenior Engagement Manager, USmark.kohler@windrosecg.comView LinkedIn profileFollow on twitter |
![]() Maja WarrumEngagement Manager, USmaja.warrum@windrosecg.comView LinkedIn profileFollow on twitter |
![]() Giovanni SalduttiSenior Consultant, USgiovanni.saldutti@windrosecg.comView LinkedIn profileFollow on twitter |
|
Windrose Consulting Group acquires Parioforma as part of its global growth strategy to further enhance its capabilities in non-traditional markets
Address:
20 Old Bailey
London
EC4M 7AN
United Kingdom